#aSAH Method Hannah Shotton 2 Introduction SAH Rupturing - - PowerPoint PPT Presentation

asah
SMART_READER_LITE
LIVE PREVIEW

#aSAH Method Hannah Shotton 2 Introduction SAH Rupturing - - PowerPoint PPT Presentation

#aSAH Method Hannah Shotton 2 Introduction SAH Rupturing aneurysm Poor outlook Intervention Secure the aneurysm: clipping or coiling Recommended 48 hours Regional Specialist NSC Conservative management 3 Introduction Previous


slide-1
SLIDE 1

#aSAH

slide-2
SLIDE 2

Method Hannah Shotton

2

slide-3
SLIDE 3
  • SAH

Rupturing aneurysm Poor outlook

  • Intervention

Secure the aneurysm: clipping or coiling Recommended 48 hours Regional Specialist NSC Conservative management

Introduction

3

slide-4
SLIDE 4
  • Previous work has focused on patients in NSC
  • This study to examine entire acute pathway

Presentation to discharge in secondary/acute and tertiary care Patients managed conservatively Patients undergoing active intervention

Introduction

4

slide-5
SLIDE 5

Expert Group:

Neurosurgery Neuroradiology Neurology Stroke medicine Acute medicine Neurocritical care and anaesthesia Neuroscience nursing Lay representative

Introduction

5

slide-6
SLIDE 6

“ To explore remediable factors in the process of care of patients admitted with the diagnosis of aneurysmal subarachnoid haemorrhage, looking at patients that underwent open surgery, interventional radiology and those managed conservatively”

Aim

6

slide-7
SLIDE 7
  • To assess the organisational structures and

policies for:

Diagnosis Decision making Definitive treatment Post treatment care Rehabilitation

Objectives

7

slide-8
SLIDE 8
  • To explore remediable factors in care of aSAH

patients including:

Initial assessment Admission process Diagnosis Decision making Treatment Rehabilitation

Objectives

8

slide-9
SLIDE 9
  • Acute hospitals in England, Wales, Northern

Ireland and the offshore islands

  • 27 Neurosurgical & Neuroscience centres

(NSCs)

  • Organisational questionnaire
  • Local Reporters, ambassadors, clinical lead

Hospital Participation

9

slide-10
SLIDE 10
  • Adults presenting to secondary or tertiary

care after suffering an aSAH

  • Data collection period:

1st July 2011 - 30th September 2011

Study Population

10

slide-11
SLIDE 11
  • ICD10 code for SAH from hospital records
  • Spreadsheet data
  • Patients transferred between hospitals:

data linked on NHS number & DoB

Identification of Patients

11

slide-12
SLIDE 12
  • Clinician questionnaires

Responsible consultant in secondary or tertiary care Non-aneurysmal SAH excluded Maximum 4 cases/ consultant

  • Case note extracts

Secondary and tertiary care Initial presentation to discharge

Data Collection

12

slide-13
SLIDE 13
  • Peer review

Multidisciplinary Advisor group Case notes plus questionnaires: secondary only, tertiary only, linked secondary/tertiary Opinion on quality of care Advisor assessment form

Data Collection

13

slide-14
SLIDE 14

Data Collection

  • Good Practice
  • Room for improvement in clinical aspects of care
  • Room for improvement in organisational aspects of care
  • Room for improvement in BOTH clinical and organisational

aspects of care

  • Less than satisfactory

14

slide-15
SLIDE 15

Case Inclusion

15

slide-16
SLIDE 16

Data Returns

16

slide-17
SLIDE 17

Organisational Data Alex Goodwin

17

slide-18
SLIDE 18

Hospital Returns

Table 2.1

18

slide-19
SLIDE 19

Clinical Networks

  • Formal

11.9%

  • Informal

86.5%

19

slide-20
SLIDE 20

Availability of Investigations

Figure 2.1

20

slide-21
SLIDE 21

Lumbar Puncture

  • 5.4% Unable to perform LP
  • 25% Unable to perform LP 24/7
  • 75% had no guidance as to who should

perform LP

21

slide-22
SLIDE 22

22

slide-23
SLIDE 23

Secondary Care - Protocols

  • Management of Acute

68% Severe Headache

  • aSAH Management

72.4%

23

slide-24
SLIDE 24

aSAH Management Protocol Includes…

Table 2.8

24

slide-25
SLIDE 25

Average Journey Time to Nearest NSC

  • Figure. 2.6

25

slide-26
SLIDE 26

Guidelines for Identifying Those for Conservative Management

  • Only in 11.5% of hospitals
  • Reasons for conservative management

Suitability for intervention Co-morbidities Conscious state Age Pre-morbid independence & cognitive state Severity of bleed

26

slide-27
SLIDE 27

Post-Procedure Support Available in Secondary Care

Table 2.20

27

slide-28
SLIDE 28

Governance - Regional Audit

Table 2.22

28

slide-29
SLIDE 29

Governance - Local Audit, M&M

Table 2.24

29

slide-30
SLIDE 30

Timing of Intervention – Good Grade

Table 2.28

30

slide-31
SLIDE 31

Timing of Intervention – Poor Grade

Table 2.29

31

slide-32
SLIDE 32

Availability of Staff

Figure 2.6

32

slide-33
SLIDE 33

In-patient Rehabilitation (NSC)

Table 2.37

33

slide-34
SLIDE 34

Services Available Post-Discharge (NSC)

Table 2.38

34

slide-35
SLIDE 35

Organisational Data Key Findings in Secondary Care

  • 32% had no protocol for managing

headache

  • 29% used WFNS grading
  • 85% within 50 miles / 1 hour of NSC
  • 70% had no formal transfer protocol

35

slide-36
SLIDE 36

Organisational Data Key Findings in Tertiary Care

  • 22/27 (81%) NSCs did not have a policy for
  • ptimal timing of definitive care
  • 20/27 NSCs (75%) had no policy for pre-
  • perative care of aSAH
  • 17/27 (63%) NSCs lacked interventional

radiology services 7 days a week

36

slide-37
SLIDE 37

Organisational Data Key Findings in Both Secondary & Tertiary Care

  • 88% not part of formal network
  • 25% of hospitals were unable to perform LPs

24/7

  • 75% lacked policies for the performance of LPs
  • 80% failed to participate in regional audit
  • 40% of secondary hospitals offered

neuropsychological support compared to 20/27 (75%) of NSCs

37

slide-38
SLIDE 38

Organisational Data Recommendations

  • Establish formal networks of care linking

secondary and tertiary care

  • Regional audit and MDT meetings should take

place in all hospitals

  • Availability of interventional neuroradiology

should allow compliance with treating patients within 48 hours of onset

38

slide-39
SLIDE 39

Secondary Care

39

slide-40
SLIDE 40

Demographics - Age

Table 3.1

40

slide-41
SLIDE 41

First Presentation to Hospital

  • Secondary care

82.4%

  • Hospital with onsite NSC

17.6%

41

slide-42
SLIDE 42

Day of Presentation

Table 3.3

42

slide-43
SLIDE 43

Time of Arrival

Table 3.4

43

slide-44
SLIDE 44

Initial Assessment – Grade of Clinician

Figure 3.3

44

slide-45
SLIDE 45

Pre-morbid Functional Status

Table 3.8

40% with Hypertension

45

slide-46
SLIDE 46

GCS at First Assessment

Figure 3.4

46

slide-47
SLIDE 47

CT Scan - Timing

Table 3.13

47

slide-48
SLIDE 48

CT Scan - Delays

Table 3.15

48

slide-49
SLIDE 49

49

slide-50
SLIDE 50

Appropriately Timed Diagnosis

Table 3.18

50

slide-51
SLIDE 51

Delayed or Overlooked Diagnosis (Advisors’ Form)

Table 3.18

Primary Care

  • 17.6% of patients

saw GP

  • Delayed or
  • verlooked in 32/75
  • Outcome affected in

23/32 Secondary Care

  • Delay or overlooked

in 12%

  • Outcome affected in

10/49

51

slide-52
SLIDE 52

52

slide-53
SLIDE 53

53

slide-54
SLIDE 54

aSAH Management in Secondary Care - Nimodipine

Table 3.26

54

slide-55
SLIDE 55

Delays in Referral Process

Table 3.35

55

slide-56
SLIDE 56

Delayed Acceptance by NSC

  • Lack of beds

13

  • Staffing issue

6

  • Other

17

  • Total

36

56

slide-57
SLIDE 57

Delay in Transfer

  • Delay in 17.9%
  • Deterioration during delayed transfer 10/47

57

slide-58
SLIDE 58

Conservative Management

Table 3.38

58

slide-59
SLIDE 59

Conservative Management

Table 3.39

59

slide-60
SLIDE 60

Conservative Management

Table 3.40

60

slide-61
SLIDE 61

Quality of Care in Secondary Care

Figure 3.6

61

slide-62
SLIDE 62

Quality of Care in Secondary Care

Table 3.43

62

slide-63
SLIDE 63

Secondary Care - Key Findings

  • 32/75 patients in primary care had diagnosis
  • verlooked
  • 12.8% of patients in secondary care did not have a

timely diagnosis

  • 51 patients experienced a delay related to their CT

scan, this delay resulted in an altered outcome for 4

  • 67.9% of patients in secondary care did not have a CT

scan within one hour of admission

63

slide-64
SLIDE 64

Secondary Care - Key Findings

  • 46.4% of patients did not receive Nimodipine

in secondary care following diagnosis

  • The decision to manage conservatively was

considered appropriate in 94.1% of patients

  • Delays in the referral process were more

common out of hours

  • 68.8% of patients received good care

64

slide-65
SLIDE 65

Secondary Care - Recommendations

  • The clinical presentation of aSAH should

be highlighted in educational programmes

  • Patients presenting with an acute severe

headache should be thoroughly examined and a CT scan performed within one hour

65

slide-66
SLIDE 66

Secondary Care - Recommendations

  • Standard protocols for the management
  • f patients with aSAH should be adopted
  • Patients diagnosed with aSAH should be

started on nimodipine

66

slide-67
SLIDE 67

Tertiary Care Michael Gough

67

slide-68
SLIDE 68

Source of Admission

(Advisors’ Form)

Table 4.1

68

slide-69
SLIDE 69

Initial Assessment in NSC

(Advisors’ Form)

Poor examination 12.1% Poor planning Ix 8.3% Table 4.6

69

slide-70
SLIDE 70

Time to Consultant Review

(Clinician Questionnaire)

Clinically important 14% Not documented 45% Unknown 93 Table 4.8

70

slide-71
SLIDE 71

Deficiencies in Admission Process

(Advisors’ Form) *

Table 4.9 *Outcome affected in 2/14 13.1%

71

slide-72
SLIDE 72

Investigations Following Admission

(Clinical Questionnaire)

73% underwent CTA: confirm aneurysm, plan Tx

*

* Data transfer crucial Table 4.10

72

slide-73
SLIDE 73

Decision on Treatment Method

(Clinical Questionnaire)

No documentation of discussion in nearly 1/4 Table 4.11

73

slide-74
SLIDE 74

Delay in Treatment Planning

(Advisors’ Form)

11/24 = delay in performing CTA/DSA Table 4.12

74

slide-75
SLIDE 75

Treatment Method for Aneurysm

(Clinical Questionnaire)

Table 4.17 26 conservative management (15 presented to tertiary hospital) International Subarachnoid Aneurysm Trial (ISAT) Dependent/dead at 60/7: 25.4% v 36.4%, RRR 22.6%

75

slide-76
SLIDE 76

Who Gave Consent?

(Clinical Questionnaire)

Table 4.15 WFNS grade I 160 II 33 III 7 IV 2

76

slide-77
SLIDE 77

Delays in Definitive Treatment

(Advisors’ Form)

5/53: outcome affected Delay in controlling aneurysm 21.6% >10% insufficient data

77

slide-78
SLIDE 78

Day of Admission Time to Treatment in 246 Patients

10 20 30 40 50 60 70 80 <24 24-48 >48 Mon-Thurs Fri-Sun

Comparison of time from admission to intervention by day of admission

78

slide-79
SLIDE 79

79

slide-80
SLIDE 80

Time to Treatment Risk of Disease-specific Complications

 

80

slide-81
SLIDE 81

Time to Treatment & Other Complications

(Advisors’ Form)

Table 4.20

81

slide-82
SLIDE 82

Time to Treatment & Other Complications

(Advisors’ Form)

Table 4.20 Table 4.18

82

slide-83
SLIDE 83

Time to Treatment Functional Status at Discharge

83

slide-84
SLIDE 84

Networks

Interventional Radiology

Surgeons

A 7-day Service

84

AUDIT

slide-85
SLIDE 85

Grade of Surgeon/Radiologist

(Clinical Questionnaire)

Table 4.22

85

slide-86
SLIDE 86

Procedural Complications

(Advisors’ Form)

Table 4.24 Rupture during treatment 7/239 & 2/44 Thromboembolic 8/239: 4 CVA Failure to occlude: 1.7% v 0.5% Access vessel occlusion: 2.1% v 0.69%

86

slide-87
SLIDE 87

Mortality Following Intervention

(Advisors’ Form)

Identical to ISAT Table 4.30

87

slide-88
SLIDE 88

Re-bleeding Post-intervention

(Clinical Questionnaire)

Table 4.32 Cochrane Review 4.2%

88

slide-89
SLIDE 89

Outcome: Re-bleeding

(Clinical Questionnaire)

Table 4.37

89

slide-90
SLIDE 90

Delayed Cerebral Ischaemia

(Clinical Questionnaire)

Table 4.39 Early brain injury > vasospasm Electrolytes, cortical spreading depression, microthrombosis

90

slide-91
SLIDE 91

Treatment of Delayed Cerebral Ischaemia

(Clinical Questionnaire)

Hypertension, Hypervolaemia, Haemodilution Table 4.41

91

slide-92
SLIDE 92

Functional Status at Discharge

The Need for Rehabilitation Services

2/3 had symptoms or disability

92

slide-93
SLIDE 93

WFNS Grade and Outcome

The Need for Rehabilitation Services

<1/4 no symptoms or disability

93

slide-94
SLIDE 94

In-patient Rehabilitation

(Advisors’ Form)

Table 4.47 Require formal assessment and planning ISAT @ 1y showed 1/3 cognitive impairment

94

slide-95
SLIDE 95

Post-discharge Support for Patients with Symptoms or Disability

Table 4.49 Advisors: inadequate in 35/164 (21.3%)

95

slide-96
SLIDE 96

Functional Status at Discharge Neuropsychology Support

Table 4.50 Good cognitive function = independent living, return to work

96

slide-97
SLIDE 97

Organ Donation

Table 5.1 50% of UK cadaveric donors = ICH 2012/13: 622/1212 Table 5.2

97

slide-98
SLIDE 98

Organ Donation Reasons for No Donation

*

Table 5.3

98

* 1/8 refused by ITU consultant

19/43 = missed opportunities Audit donation rates Develop policies to increase

slide-99
SLIDE 99

Recommendations - Tertiary Care

99

  • Relevant professional bodies should develop nationally-

agreed & audited protocols that include: Initial assessment and decision-making (MDT) with documentation Informed consent Timing of intervention Perioperative care Management of complications Rehabilitation

  • Mental capacity of aSAH patients to give their own consent

should be reviewed and a consensus document developed

slide-100
SLIDE 100

Recommendations Tertiary Care

100

  • The nationally agreed standard (National Clinical Guideline

for Stroke) of securing ruptured aneurysms within 48 hours should be met consistently and comprehensively by the clinicians treating this group of patients. This will require providers to assess the service they deliver and move towards 7 day working

  • Sufficient training opportunities for trainees to achieve

competence

  • Appropriately funded rehabilitation for all patients following

an aSAH

slide-101
SLIDE 101

Summary: Delays

184 patients suffered a delay 68 patients had deficiencies in care that affected outcome Primary 25 Secondary 33 Tertiary 10 Table 6.1 First Delay 20% 44% 36%

101

slide-102
SLIDE 102

Overall Quality of Care

Secondary & Tertiary Hospitals

20 care: 68.5% 30 care: 53.8%

102

20 care: 1.6% 30 care: 11.2%

slide-103
SLIDE 103

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died Treatment delayed > 48h  re-bleeding  complications  disability No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died

Education & protocols for the management of severe headache

103

slide-104
SLIDE 104

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died Treatment delayed > 48h  re-bleeding  complications  disability No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died

Standard protocols for networks: management in secondary care

104

slide-105
SLIDE 105

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died

Formal networks and protocols for transfer

105

slide-106
SLIDE 106

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died Treatment delayed > 48h  re-bleeding  complications  disability No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died

National protocols: management tertiary care

106

slide-107
SLIDE 107

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died Treatment delayed > 48h  re-bleeding  complications  disability No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died Conservative Management 136/150 died Radiology/Surgery 19/277 died

238/427 patients survived, many requiring rehabilitation

107

slide-108
SLIDE 108

Summary & Key Recommendations

427 patients

Poor assessment 132/427 26 affected 9 died Delayed assessment 25/336 7 affected 3 died CT delay 51/390 4 affected 3 died 303 accepted NSC 36 delayed 2 died Transfer delayed 47/303 10 deteriorated 5 died Treatment delayed > 48h  re-bleeding  complications  disability No nimodipine 143/269 20 Care: 24 missed 17 affected 4 died 10 Care: 32/75 missed 23 affected 8 died Conservative Management/ No intervention 136/150 died Radiology/Surgery 19/277died

155/427 (36%) patients with aSAH died

108

slide-109
SLIDE 109

Thank you www.ncepod.org.uk

109

slide-110
SLIDE 110